Pamela M. Pollock

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell et al. · Journal of Clinical Oncology · 2020 · 837 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

Ellen Stelloo, Tjalling Bosse, Remi A. Nout et al. · Modern Pathology · 2015 · 490 citations · Full text

Medicine, Gynecology, Oncology +12

Integrated genomic characterization of endometrial carcinoma

Gad Getz, Stacey Gabriel, Kristian Cibulskis et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2013 · 414 citations · Full text

Medicine, Genetics, Oncology +17

Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells

Jian‐Zhong Qin, Jeffrey Ziffra, Lawrence Stennett et al. · Cancer Research · 2005 · 338 citations

Medicine, Oncology, Pharmacology +16

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

Pamela M. Pollock, Michael G. Gartside, L C Dejeza et al. · Oncogene · 2007 · 307 citations · Full text

Medicine, Genetics, Molecular Genetics +16